Learn Your Way to A Healthier Life
iHealth Statement on the COVID-19 Omicron Variant and Its At-Home Test Kit's Effectiveness
iHealth has been continuously monitoring the COVID-19 variants so the iHealth COVID-19 Antigen Rapid Test is ready to address any significant changes in the epidemic. We are confident that our rapid antigen test continues to detect COVID-19 infection, including infection with the Omicron variant.
Stop the Spread With iHealth's New COVID-19 Self-Test Kit
iHealth Labs, Inc. announced today the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. This self-test is suitable for individual or group testing anytime, anywhere, and delivers test results in 15 minutes at home. It is authorized and available for purchase at iHealthLabs.com in packages of two test kits.
